Lista de obras - Sandra Guidi - Dominio Público Uruguay

A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.

artículo científico publicado en 2017

ABNORMAL DEVELOPMENT OF THE INFERIOR TEMPORAL REGION IN FETUSES WITH DOWN SYNDROME.

artículo científico publicado en 2018

APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome.

artículo científico publicado en 2011

Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome

artículo científico publicado en 2013

Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome

artículo científico publicado en 2010

Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome

artículo científico publicado en 2012

Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression

artículo científico publicado en 2012

Effects of early environment on pyramidal neuron morphology in field CA1 of the guinea-pig.

artículo científico publicado en 2003

Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome?

artículo científico publicado en 2017

Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period

artículo científico publicado en 2011

Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome

artículo científico publicado en 2015

Lithium Restores Age-related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome

artículo científico publicado en 2016

Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down syndrome

artículo científico publicado en 2009

Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome

artículo científico publicado en 2017

Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice

artículo científico publicado en 2014

Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig.

artículo científico publicado en 2007

Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome

scientific article published on 11 May 2019

Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.

artículo científico publicado en 2017

Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome.

artículo científico publicado en 2007

Neurogenesis impairment: An early developmental defect in Down syndrome.

artículo científico publicado en 2017

Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation

artículo científico publicado en 2002

Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide

artículo científico publicado en 2002

Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome

artículo científico publicado en 2013

Postnatal neurogenesis in the dentate gyrus of the guinea pig.

artículo científico publicado en 2005

Postnatal neurogenesis in the hippocampal dentate gyrus and subventricular zone of the Göttingen minipig

artículo científico publicado en 2011

Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.

artículo científico publicado en 2013

Sex differences in the hippocampal dentate gyrus of the guinea-pig before puberty ⬇️

artículo científico publicado el 1 de enero de 2003

Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome

artículo científico publicado en 2016

Subicular hypotrophy in fetuses with down syndrome and in the ts65dn model of down syndrome

scientific article published on 15 November 2018

Targeting APP/AICD in Down syndrome

artículo científico publicado en 2017

The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome

artículo científico publicado en 2021

Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse

artículo científico publicado en 2019

Timing of therapies for Down syndrome: the sooner, the better

artículo científico publicado en 2015

Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome

artículo científico publicado en 2018

Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome.

artículo científico publicado en 2010

Lista de obras de Sandra Guidi

A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.

ABNORMAL DEVELOPMENT OF THE INFERIOR TEMPORAL REGION IN FETUSES WITH DOWN SYNDROME.

APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome.

Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome

Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome

Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome

Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression

Effects of early environment on pyramidal neuron morphology in field CA1 of the guinea-pig.

Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome?

Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period

Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome

Lithium Restores Age-related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome

Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down syndrome

Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome

Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice

Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig.

Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome

Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.

Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome.

Neurogenesis impairment: An early developmental defect in Down syndrome.

Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation

Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide

Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome

Postnatal neurogenesis in the dentate gyrus of the guinea pig.

Postnatal neurogenesis in the hippocampal dentate gyrus and subventricular zone of the Göttingen minipig

Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.

Sex differences in the hippocampal dentate gyrus of the guinea-pig before puberty ⬇️

Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome

Subicular hypotrophy in fetuses with down syndrome and in the ts65dn model of down syndrome

Targeting APP/AICD in Down syndrome

The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome

Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse

Timing of therapies for Down syndrome: the sooner, the better

Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome

Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome.